Clinical Trial Update: Aging Mammary Stem Cells and Breast Cancer Prevention [Phase 2]

View source ↗

Summary

Phase 2 clinical trial on aging mammary stem cells for breast cancer prevention was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: LuZhe Sun | Conditions: Cancer of Breast | Phase 2 | Status: TERMINATED | Results posted: 2023-12-05